Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 385,693 | 270,600 | 50,037 | 0 | 0 |
| Cost of Goods | 33,303 | 26,065 | 5,198 | N/A | N/A |
| Gross Profit | 352,390 | 244,535 | 44,839 | N/A | N/A |
| Operating Expenses | 633,255 | 476,425 | 224,836 | 124,707 | 99,141 |
| Operating Income | -280,562 | -231,825 | -179,799 | -124,707 | -99,141 |
| Interest Expense | 6,569 | 6,453 | 7,335 | 5,696 | 2,566 |
| Other Income | 0 | 0 | 0 | 0 | -1,194 |
| Pre-tax Income | -287,131 | -238,278 | -187,134 | -130,403 | -102,901 |
| Income Tax | 85 | 960 | N/A | N/A | N/A |
| Net Income Continuous | -287,216 | -239,238 | -187,134 | -130,403 | -102,901 |
| Net Income | $-287,216 | $-239,238 | $-187,134 | $-130,403 | $-102,901 |
| EPS Basic Total Ops | -5.99 | -5.27 | -4.60 | -3.47 | -2.77 |
| EPS Basic Continuous Ops | -5.99 | -5.27 | -4.60 | -3.47 | -2.77 |
| EPS Diluted Total Ops | -5.99 | -5.27 | -4.60 | -3.47 | -2.77 |
| EPS Diluted Continuous Ops | -5.99 | -5.27 | -4.60 | -3.47 | -2.77 |
| EPS Diluted Before Non-Recurring Items | -3.93 | -2.67 | -4.42 | -3.47 | -2.74 |
| EBITDA(a) | $-269,964 | $-222,417 | $-173,914 | $-123,554 | $-98,277 |